Healthcare News

RANCHO CUCAMONGA, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its third quarter of 2014 ended September...

LINCOLN, Neb., Nov. 4, 2014 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced results for the third quarter of 2014. Net New Sales $8.1 million, up...

ROCKVILLE, Md., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) a specialty pharmaceutical company focused on developing and commercializing products for the treatment of...

ATLANTA, GA--(Marketwired - Nov 4, 2014) -  ExamWorks Group, Inc. (NYSE: EXAM), a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance, case...

Revenue of $168.8 million; diluted EPS of $0.21; adjusted EPS of $0.25 myRisk Hereditary Cancer revenue of $53.1 million, up 95 percent sequentially Draft Medicare decision covering...

PALO ALTO, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...

– Reports Record Revenue, Cash Reimbursement and Test Volumes – – Company to Host Conference Call and Webcast Today at 1:30 p.m. PST – IRVINE, Calif., Nov. 4, 2014 (GLOBE...

REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial...

EMERYVILLE, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today reported a net loss attributable to common stockholders of $9.6 million, or $0.57 per share, for...

Raises Year-End Cash Balance Guidance to Over $225 Million From $215 Million Management to Host Call at 4:30 pm ET to Discuss Quarter and Pipeline Advances REDWOOD CITY, Calif., Nov. 4, 2014...